- Home
- BMEA vs AIP Comparison
BMEA vs AIP Comparison
Compare BMEA & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- AIP
- Stock Information
- Founded
- BMEA 2017
- AIP 2003
- Country
- BMEA United States
- AIP United States
- Employees
- BMEA N/A
- AIP N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- AIP Semiconductors
- Sector
- BMEA Health Care
- AIP Technology
- Exchange
- BMEA Nasdaq
- AIP Nasdaq
- Market Cap
- BMEA 275.6M
- AIP 277.9M
- IPO Year
- BMEA 2021
- AIP 2021
- Fundamental
- Price
- BMEA $6.38
- AIP $8.45
- Analyst Decision
- BMEA Buy
- AIP Strong Buy
- Analyst Count
- BMEA 13
- AIP 4
- Target Price
- BMEA $37.25
- AIP $13.00
- AVG Volume (30 Days)
- BMEA 814.9K
- AIP 127.5K
- Earning Date
- BMEA 10-29-2024
- AIP 11-05-2024
- Dividend Yield
- BMEA N/A
- AIP N/A
- EPS Growth
- BMEA N/A
- AIP N/A
- EPS
- BMEA N/A
- AIP N/A
- Revenue
- BMEA N/A
- AIP $54,739,000.00
- Revenue This Year
- BMEA N/A
- AIP $7.87
- Revenue Next Year
- BMEA N/A
- AIP $19.23
- P/E Ratio
- BMEA N/A
- AIP N/A
- Revenue Growth
- BMEA N/A
- AIP 4.53
- 52 Week Low
- BMEA $3.61
- AIP $4.83
- 52 Week High
- BMEA $22.74
- AIP $9.54
- Technical
- Relative Strength Index (RSI)
- BMEA 24.23
- AIP 62.90
- Support Level
- BMEA $6.04
- AIP $7.58
- Resistance Level
- BMEA $9.34
- AIP $8.22
- Average True Range (ATR)
- BMEA 0.54
- AIP 0.47
- MACD
- BMEA -0.26
- AIP 0.04
- Stochastic Oscillator
- BMEA 10.30
- AIP 87.69
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About AIP Arteris Inc.
Arteris Inc is a developer of on-chip interconnect fabric technology designed for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The company's technology is used in System-on-Chip (SoC) and provides software and services to automate SoC integration, enabling users to efficiently deploy NoC IP, and offer IP support, maintenance services, professional services, and training and on-site support services. The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.